skip to main content
Refinado por: Base de dados/Biblioteca: EBSCO_MEDLINE Complete(医学期刊全文数据库) remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Targeted mutational profiling of peripheral T-cell lymphoma not otherwise specified highlights new mechanisms in a heterogeneous pathogenesis
Material Type:
Artigo
Adicionar ao Meu Espaço

Targeted mutational profiling of peripheral T-cell lymphoma not otherwise specified highlights new mechanisms in a heterogeneous pathogenesis

Schatz, J H ; Horwitz, S M ; Teruya-Feldstein, J ; Lunning, M A ; Viale, A ; Huberman, K ; Socci, N D ; Lailler, N ; Heguy, A ; Dolgalev, I ; Migliacci, J C ; Pirun, M ; Palomba, M L ; Weinstock, D M ; Wendel, H-G

Leukemia, 2015-01, Vol.29 (1), p.237-241 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

2
Characterization of cytokine release syndrome (CRS) and neurological events (NEs) in the phase I TRANSCEND NHL 001 trial of lisocabtagene maraleucel (liso-cel) for patients (pts) with relapsed/refractory (R/R) large B-cell lymphoma (LBCL)
Material Type:
Artigo
Adicionar ao Meu Espaço

Characterization of cytokine release syndrome (CRS) and neurological events (NEs) in the phase I TRANSCEND NHL 001 trial of lisocabtagene maraleucel (liso-cel) for patients (pts) with relapsed/refractory (R/R) large B-cell lymphoma (LBCL)

Abramson, Jeremy S. ; Siddiqi, Tanya ; Gordon, Leo I. ; Lunning, Matthew Alexander ; Wang, Michael ; Arnason, Jon E. ; Mehta, Amitkumar N. ; Purev, Enkhee ; Maloney, David G. ; Andreadis, Charalambos ; Sehgal, Alison R. ; Solomon, Scott R. ; Ghosh, Nilanjan ; Albertson, Tina M. ; Garcia, Jacob ; Kostic, Ana ; Li, Daniel ; Kim, Yeonhee ; Palomba, Maria Lia

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e20046-e20046 [Periódico revisado por pares]

Texto completo disponível

3
COMBINATION OF TGR‐1202, UBLITUXIMAB, AND BENDAMUSTINE IS SAFE AND HIGHLY ACTIVE IN PATIENTS WITH ADVANCED DLBCL AND FOLLICULAR LYMPHOMA
Material Type:
Artigo
Adicionar ao Meu Espaço

COMBINATION OF TGR‐1202, UBLITUXIMAB, AND BENDAMUSTINE IS SAFE AND HIGHLY ACTIVE IN PATIENTS WITH ADVANCED DLBCL AND FOLLICULAR LYMPHOMA

Lunning, M.A. ; Vose, J.M. ; Bierman, P.J. ; Bociek, G. ; Schreeder, M.T. ; Siddiqi, T. ; Blumel, S.M. ; Cutter, K. ; Pauli, E.K. ; Bui, D. ; Sportelli, P. ; Miskin, H.P. ; Purdom, M. ; Weiss, M.S. ; Fowler, N.H.

Hematological oncology, 2017-06, Vol.35 (S2), p.266-267 [Periódico revisado por pares]

Chichester: Wiley Subscription Services, Inc

Texto completo disponível

4
CHEMO‐FREE TRIPLET COMBINATION OF TGR‐1202, UBLITUXIMAB, AND IBRUTINIB IS WELL TOLERATED AND HIGHLY ACTIVE IN PATIENTS WITH ADVANCED CLL AND NHL
Material Type:
Artigo
Adicionar ao Meu Espaço

CHEMO‐FREE TRIPLET COMBINATION OF TGR‐1202, UBLITUXIMAB, AND IBRUTINIB IS WELL TOLERATED AND HIGHLY ACTIVE IN PATIENTS WITH ADVANCED CLL AND NHL

Nastoupil, L. ; Lunning, M.A. ; Vose, J.M. ; Schreeder, M.T. ; Siddiqi, T. ; Flowers, C.R. ; Cohen, J.B. ; Burger, J.A. ; Wierda, W.G. ; O'Brien, S. ; Sportelli, P. ; Miskin, H.P. ; Purdom, M.A. ; Weiss, M.S. ; Fowler, N.H.

Hematological oncology, 2017-06, Vol.35 (S2), p.112-113 [Periódico revisado por pares]

Chichester: Wiley Subscription Services, Inc

Texto completo disponível

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Buscando em bases de dados remotas. Favor aguardar.